1121 - 1130 of 6256 Results
Title
Year
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 6
-
OPENTitle: Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disordersJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 26Issue #: 6Start Page: 101117End Page: 101117Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.gim.2024.101117Best OA location URL: https://doi.org/10.1016/j.gim.2024.101117Citation Count: 2
-
OPENTitle: Identification and structural characterization of small molecule inhibitors of PINK1Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-58285-3Best OA location URL: https://www.nature.com/articles/s41598-024-58285-3.pdfCitation Count: 3
- Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson’s Disease Psychosis2025OPENTitle: Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson’s Disease PsychosisJournal Name: BMJ Mental HealthPublisher: BMJVol: 28Issue #: 1Start Page: e301430End Page: e301430Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjment-2024-301430Best OA location URL: https://doi.org/10.1136/bmjment-2024-301430Citation Count: 0
-
OPENTitle: An invisible ubiquitin conformation is required for efficient phosphorylation by PINK 1Journal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 36Issue #: 24Start Page: 3555End Page: 3572Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.15252/embj.201797876Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201797876Citation Count: 58
- Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum2019OPENTitle: Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat StriatumJournal Name: NeurosciencePublisher: Elsevier BVVol: 409Issue #:Start Page: 169End Page: 179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.04.033Best OA location URL: https://doi.org/10.1016/j.neuroscience.2019.04.033Citation Count: 47
- Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease2021OPENTitle: Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01117-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01117-yCitation Count: 27
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10147382Citation Count: 46
- Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face Validity2020OPENTitle: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face ValidityJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 11Start Page: 3216End Page: 3216Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20113216Best OA location URL: https://www.mdpi.com/1424-8220/20/11/3216/pdf?version=1591769863Citation Count: 33
- Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease2024OPENTitle: Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 147Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-024-02706-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-024-02706-0.pdfCitation Count: 39